Iovance Biotherapeutics, Inc. logo

IOVA

Iovance Biotherapeutics, Inc.

$6.27

Earnings Summary

Revenue
$0.47Mn
Net Profits
$-113.76Mn
Net Profit Margins
-24255.86%

Highlights

Revenue:

Iovance Biotherapeutics, Inc.’s revenue jumped +Inf% since last year same period to $0.47Mn in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 97.06% jump in its revenue since last 3-months.

Net Profits:

Iovance Biotherapeutics, Inc.’s net profit fell -15.09% since last year same period to $-113.76Mn in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated -6.79% fall in its net profits since last 3-months.

Net Profit Margins:

Iovance Biotherapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -24255.86% in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 45.81% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Iovance Biotherapeutics, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.44
EPS Estimate Current Year
-0.44

Highlights

EPS Estimate Current Quarter:

Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a 2.22% jump from last quarter’s estimates.

EPS Estimate Current Year:

Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.44.

Key Ratios

Key ratios of the Iovance Biotherapeutics, Inc. post its Q3 2023 earnings

Earning Per Share (EPS)
-0.46

Highlights

Earning Per Share (EPS):

Iovance Biotherapeutics, Inc.’s earning per share (EPS) jumped 26.98% since last year same period to -0.46 in the Q3 2023. This indicates that the Iovance Biotherapeutics, Inc. has generated 26.98% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-07
-0.45
-0.46
-2.22%
2023-08-08
-0.8
-0.47
41.25%
2023-05-10
-0.74
-0.5
32.43%